IL6 and Parkinson disease: In this study, IL-6 level in CSF in PD-CI group is not only prominently enhanced comparing with PD-NCI group, but also has a strikingly negative correlation with MoCA score, indicating that IL-6 may be a potential neuroinflammatory biomarker for the development and severity of cognitive impairment in PD patients.